My confessional. My reggaetón or PhD diary. A space pa’ soltar lo que duele, lo que pesa, lo que formó esta versión de mí. Let’s write, even if it’s offbeat.
So grateful that my lab is celebrating its 25th anniversary next week! Super lucky to work with such an inspiring team that made this possible 🙏🏼🙏🏼🙏🏼
Join us as we celebrate our 25th anniversary with a special symposium 🤗 @YaleMed
Últimamente he pensado en usar esta cuenta para soltar.
Para escribir, recordar, cuestionar.
Para contar lo que me marcó, aunque no siempre sepa por dónde empezar.
No sé si será terapia o bochinche.
Autocrítica o autoexposición.
Lo único que sé… es que no sé.
Lately I’ve been thinking about using this account to let go.
To write, question, remember.
To tell the stories that shaped me—even when I don’t know where to start.
Not sure if it’s therapy or just gossip.
Self-critique or self-exposure.
What I do know… is that I don’t know.
What determines whether someone gets infected or not after exposure to SARS-CoV-2? A new study by Lindeboom et al examined this question with COVID-19 human challenge study. @BenIsraelow and I summarize their key findings in this News & Views 🧵 (1/)
https://t.co/11PzBqeor1
HOMENAJE AL CAQUETÁ
El departamento de Caquetá tiene 16 municipios, casi todos ubicados en el piedemonte y de tamaño reducido, excepto por tres, que se extienden Amazonia adentro, y equivalen al 88 de toda su superficie. Aquí van todos.
🧵👇🏻
For everything you want to know about immune memory (and more!) we wrote this review as part of the “Guide to” series. With @noralam_ and YoonSeung Lee
@Columbia_MI@ColumbiaMed
We learned a lot about human cell count and size from this recent @PNASNews paper
https://t.co/i9qKqFOaVB
Now made into a nice graphic https://t.co/JIxEH1B75D
We need a variant-proof Covid vaccine that protects vs. all relevant sarbecoviruses. Here's a very good candidate
https://t.co/UJzKWgMNhU
@natBME@JonathanHeeney@Cambridge_Uni
There are many such pan-coronavirus vaccine candidates that need to move forward in clinical trials
So pleased to report that our Mount Sinai-Yale long COVID (MY-LC) paper with @putrinolab & others is now published!! Proud of the hard work of all who contributed. We found biological signatures that can distinguish people with vs. without #longCOVID (1/) https://t.co/t8ARWBKLsQ
We are searching for researchers in Molecular Epidemiology and Pathogen Genomics to join our amazing Community at the Division of Infectious Diseases and Vaccinology at the School of Public Health @UCBerkeleySPH! Please spread the word and apply! https://t.co/6zyebkWQU8
Looking forward to our next #globalimmuno talk this Wednesday August 24 at 9am PST noon EST 4pm GMT by Dr. Rafi Ahmed.
Title: "Immune Memory to COVID-19"
LINK: https://t.co/2Tdtm2QoUL
¡Gracias @inmunoacoi por el apoyo! Evaluamos la respuesta inmune inducida por vacunas para la COVID-19 de ARNm (Moderna, Pfizer), vector viral (J&J) y de proteína recombinante (Novavax) en individuos vacunados pero no infectados
Artículo del Instituto de Inmunología de la Jolla CA comparando la respuesta inmune humoral y celular de cuatro #vacunas contra #SARSCoV2 & #Covid19 con la participación de nuestro miembro de la ACOI @jmateust
https://t.co/fjaRdZC0Mf
We know that #COVID-19 vaccines work in reducing hospitalizations and death cases. But, what are the differences in the responses induced by the COVID-19 vaccines? We worked on the head-to-head evaluation of the longitudinal immunity induced by COVID-19 vaccines
During the Delta wave in Israel, the importance of hybrid immunity, a booster shot, or prior Covid for protection from infections. In @NEJM today https://t.co/tDjnmxsnSr
@MiloLabWIS@WeizmannScience@TechnionLive@IsraelMOH
#CURSOS#lanzamiento
La Asociación Colombiana de Parasitología #ACPTM2022 te invita a participar de los cursos pre congreso que han sido diseñados desde distintas áreas del conocimiento 👉desliza para conocerlos.
⬇️